Ginkgo Bioworks Holdings (DNABW) Enterprise Value Growth (1y) (2020 - 2026)
Ginkgo Bioworks Holdings (DNABW) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ginkgo Bioworks Holdings |
- |
- |
16.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
53.95% |
| Dec 31, 2025 |
24.74% |
| Sep 30, 2025 |
81.98% |
| Jun 30, 2025 |
72.13% |
| Mar 31, 2025 |
62.83% |
| Dec 31, 2024 |
40.52% |
| Sep 30, 2024 |
41.27% |
| Jun 30, 2024 |
33.95% |
| Mar 31, 2024 |
30.32% |
| Dec 31, 2023 |
28.25% |
| Sep 30, 2023 |
19.14% |
| Jun 30, 2023 |
17.82% |
| Mar 31, 2023 |
17.38% |
| Dec 31, 2022 |
11.57% |
| Sep 30, 2022 |
22.42% |
| Jun 30, 2022 |
-470.40% |
| Mar 31, 2022 |
-373.74% |
| Dec 31, 2021 |
-299.86% |
| Sep 30, 2021 |
-255.08% |
| Dec 31, 2020 |
24.87% |
